$0.194
+0.007 (+3.41%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Context Therapeutics Inc (CNTX) Moving Averages Convergence Divergence (MACD) indicator is -0.04, suggesting CNTX is Strong sell.
Context Therapeutics Inc (CNTX) 20-Day simple moving average is 0.23, while Context Therapeutics Inc (CNTX) share price is $—, making it Sell.
Context Therapeutics Inc (CNTX) 60-Day simple moving average is 0.33, while Context Therapeutics Inc (CNTX) share price is $—, making it Sell.
Technical Analysis for CNTX
AI Technical CNTXAs of 2026-11-07, the technical board for Context Therapeutics Inc (CNTX) reads strong sell: 2 indicators are flashing buy, 9 are indicating sell, and 2 are neutral. Price at $0.19 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 30.23, MACD stands at -0.0358 (Sell), Stochastic %K stands at 12.938 (Buy), Stochastic %D stands at 11.805 and CCI stands at -108.234 (Buy).
CNTX trades below the 60-day SMA (0.33) and below the 200-day SMA (1.42). Immediate resistance sits at Classic R1 0.24, then R2 0.28. Support sits at Classic S1 0.17, then S2 0.14.
Context Therapeutics Inc (CNTX) Support & Resistance Level
Context Therapeutics Inc (CNTX) Technical Indicators
2026-11-07
| Name | Value |
|---|---|
| RSI_14 | 30.230 |
| STOCHk_14_3_3 | 12.938 |
| STOCHd_14_3_3 | 11.805 |
| CCI_20 | -108.234 |
| AO_5_34 | -0.075 |
| MOM_10 | -0.046 |
| MACD_12_26_9 | -0.036 |
Context Therapeutics Inc (CNTX) Relative Strength Index (RSI_14) is 30.230, creating a Neutral signal.
Context Therapeutics Inc (CNTX) Stochastic %K is 12.938, creating a Buy signal.
Context Therapeutics Inc (CNTX) Stochastic %D is 11.805, creating a Buy signal.
Context Therapeutics Inc (CNTX) CCI_20 is -108.234, creating a Buy signal.
Context Therapeutics Inc (CNTX) Awesome Oscillator (AO) is -0.075, creating a Sell signal.
Context Therapeutics Inc (CNTX) Momentum (MOM) is -0.046, creating a Sell signal.
Context Therapeutics Inc (CNTX) Moving Average Convergence Divergence (MACD) is -0.036, creating a Sell signal.
Context Therapeutics Inc (CNTX) Moving Average
2026-11-07
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 0.196 | Sell |
| MA_10 | 0.206 | Sell |
| MA_20 | 0.228 | Sell |
| MA_60 | 0.332 | Sell |
| MA_200 | 1.422 | Sell |
| MA_250 | 1.390 | Sell |
Context Therapeutics Inc (CNTX) 5-Day simple moving average is 0.196, while Context Therapeutics Inc (CNTX) share price is $, making it a Sell.
Context Therapeutics Inc (CNTX) 10-Day simple moving average is 0.206, while Context Therapeutics Inc (CNTX) share price is $, making it a Sell.
Context Therapeutics Inc (CNTX) 20-Day simple moving average is 0.228, while Context Therapeutics Inc (CNTX) share price is $, making it a Sell.
Context Therapeutics Inc (CNTX) 60-Day simple moving average is 0.332, while Context Therapeutics Inc (CNTX) share price is $, making it a Sell.
Context Therapeutics Inc (CNTX) 200-Day simple moving average is 1.422, while Context Therapeutics Inc (CNTX) share price is $, making it a Sell.
Context Therapeutics Inc (CNTX) 250-Day simple moving average is 1.390, while Context Therapeutics Inc (CNTX) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.